131 related articles for article (PubMed ID: 36266046)
1. Tranexamic Acid After Aneurysmal Subarachnoid Hemorrhage: Post Hoc Analysis of the ULTRA Trial.
Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; Van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; Bienfait HP; Boogaarts H; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWM; Vandertop WP; Verbaan D;
Neurology; 2022 Dec; 99(23):e2605-e2614. PubMed ID: 36266046
[TBL] [Abstract][Full Text] [Related]
2. Ultra-Early and Short-Term Tranexamic Acid Treatment in Patients With Good- and Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
Tjerkstra MA; Post R; Germans MR; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Wolfs JFC; De Beer FC; Kieft HH; Nanda D; Van Der Pol B; Roks G; De Beer F; Reichman LJA; Brouwers PJAM; Kwa VIH; Van Der Ree TC; Bienfait HP; Boogaarts HD; Klijn CJ; Visser V; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
Neurology; 2024 Jun; 102(12):e209169. PubMed ID: 38788175
[TBL] [Abstract][Full Text] [Related]
3. Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial.
Post R; Germans MR; Tjerkstra MA; Vergouwen MDI; Jellema K; Koot RW; Kruyt ND; Willems PWA; Wolfs JFC; de Beer FC; Kieft H; Nanda D; van der Pol B; Roks G; de Beer F; Halkes PHA; Reichman LJA; Brouwers PJAM; van den Berg-Vos RM; Kwa VIH; van der Ree TC; Bronner I; van de Vlekkert J; Bienfait HP; Boogaarts HD; Klijn CJM; van den Berg R; Coert BA; Horn J; Majoie CBLM; Rinkel GJE; Roos YBWEM; Vandertop WP; Verbaan D;
Lancet; 2021 Jan; 397(10269):112-118. PubMed ID: 33357465
[TBL] [Abstract][Full Text] [Related]
4. Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan.
Post R; Germans MR; Coert BA; Rinkel GJE; Vandertop WP; Verbaan D
Trials; 2020 Feb; 21(1):199. PubMed ID: 32070395
[TBL] [Abstract][Full Text] [Related]
5. Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial.
Germans MR; Post R; Coert BA; Rinkel GJ; Vandertop WP; Verbaan D
Trials; 2013 May; 14():143. PubMed ID: 23680226
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
Wolf S; Mielke D; Barner C; Malinova V; Kerz T; Wostrack M; Czorlich P; Salih F; Engel DC; Ehlert A; Staykov D; Alturki AY; Sure U; Bardutzky J; Schroeder HWS; Schürer L; Beck J; Juratli TA; Fritsch M; Lemcke J; Pohrt A; Meyer B; Schwab S; Rohde V; Vajkoczy P;
JAMA Neurol; 2023 Aug; 80(8):833-842. PubMed ID: 37330974
[TBL] [Abstract][Full Text] [Related]
7. Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis.
Rynkowski CB; Hegele V; Soares PHR; Tonello ML; Petterson L; Gomes FK; Rabinstein AA; Bastos LSL; Turon R; Gonçalves B; Righy C; Bozza FA; Kurtz P
Neurocrit Care; 2023 Aug; 39(1):191-197. PubMed ID: 37131089
[TBL] [Abstract][Full Text] [Related]
8. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
[TBL] [Abstract][Full Text] [Related]
9. Impact of time to start of tranexamic acid treatment on rebleed risk and outcome in aneurysmal subarachnoid hemorrhage.
Germans MR; Tjerkstra MA; Post R; Brenner A; Vergouwen MD; Rinkel GJ; Roos YB; van den Berg R; Coert BA; Vandertop WP; Verbaan D;
Eur Stroke J; 2024 Apr; ():23969873241246591. PubMed ID: 38606724
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tranexamic acid in aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials.
Liu T; Wu L; Xue R; Ding H
Am J Emerg Med; 2021 Dec; 50():646-653. PubMed ID: 34879481
[TBL] [Abstract][Full Text] [Related]
11. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Shi M; Yang C; Chen ZH; Xiao LF; Zhao WY
Front Surg; 2021; 8():790149. PubMed ID: 35083272
[TBL] [Abstract][Full Text] [Related]
13. Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
Güresir E; Lampmann T; Bele S; Czabanka M; Czorlich P; Gempt J; Goldbrunner R; Hurth H; Hermann E; Jabbarli R; Krauthausen M; König R; Lindner D; Malinova V; Meixensberger J; Mielke D; Németh R; Darkwah Oppong M; Pala A; Prinz V; Rashidi A; Roder C; Sandalcioglu IE; Sauvigny T; Schebesch KM; Timmer M; Vajkoczy P; Wessels L; Wild F; Wilhelm C; Wostrack M; Vatter H; Coch C
Int J Stroke; 2023 Feb; 18(2):242-247. PubMed ID: 35361026
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid for subarachnoid hemorrhage: A systematic review and meta-analysis.
Feng Y; Chen H
Am J Emerg Med; 2021 Dec; 50():748-752. PubMed ID: 34879498
[TBL] [Abstract][Full Text] [Related]
15. Commentary on Post,
Lo BWY; Fukuda H; Tsang ACO; Langer DJ; Miyawaki S; Koyanagi M; Lui MW
Surg Neurol Int; 2021; 12():156. PubMed ID: 33948326
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
J Neurosurg; 2019 Feb; 132(2):400-407. PubMed ID: 30717052
[TBL] [Abstract][Full Text] [Related]
18. Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study.
Post R; Germans MR; Boogaarts HD; Ferreira Dias Xavier B; Van den Berg R; Coert BA; Vandertop WP; Verbaan D
PLoS One; 2019; 14(2):e0211868. PubMed ID: 30730957
[TBL] [Abstract][Full Text] [Related]
19. Antifibrinolytic treatment in subarachnoid hemorrhage.
Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
[TBL] [Abstract][Full Text] [Related]
20. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.
Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M;
J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
